Business Standard

drugs

Pharma companies on track with QR codes to combat counterfeit drugs

The pharma industry has welcomed the DCGI mandate as they view it as a positive step to combat counterfeit drugs and ensure patient safety

Pharma companies on track with QR codes to combat counterfeit drugs
Updated On : 17 Jul 2024 | 9:10 PM IST

Antidiabetic drug Semaglutide linked to potential vision loss: Study

Researchers say future study required to assess causality

Antidiabetic drug Semaglutide linked to potential vision loss: Study
Updated On : 14 Jul 2024 | 10:13 PM IST

Pune bar drug video case: Police custody of 10 accused extended till July 3

A court here on Monday extended till July 3 the police custody of 10 persons arrested in connection with the Pune bar drug video case. Santosh Kamthe, Vitthal Kamthe, Yogendra Girase, Ravi Maheshwari, Akshay Kamthe, Dinesh Mankar, Rohan Gaikwad, Manas Mallick, who are associated with Liquid Leisure Lounge (L3), and Nitin Thombre and Karan Mishra, who were allegedly seen in the viral video, were produced in a court where police sought extension of custody. The prosecution, while seeking custody, told the court they want to probe the links of the accused with the alleged drug peddlers in the case and, therefore, need their further police custody. One of the arrested persons, Abhishek Sonawane, had supplied drugs to Thombre and Mishra and police wanted to reach the main drug peddler, the prosecution told court. Police said they arrested Abhishek Sonawane, Omkar Sakat and one Nigerian national for supplying drugs to Mishra and Thombre. Later, Aryan Patil and Akshay Swami were held for

Pune bar drug video case: Police custody of 10 accused extended till July 3
Updated On : 02 Jul 2024 | 7:04 AM IST

DRI seizes contraband worth Rs 3,500 cr in FY24, drugs major contributor

Revenue Intelligence officers have seized contrabands worth Rs 3,500 crore in 2023-24 fiscal, with narcotic drugs and gold seizures constituting a major chunk, a top official said on Thursday. Directorate of Revenue Intelligence Principal DG Mohan Kumar Singh said infiltration of supply chains has emerged as a significant challenge in curbing smuggling. Also, growing use of air passenger, courier and postal cargo for smuggling of drugs and other contrabands remains a concern. "In FY 2023-24, DRI detected 623 smuggling cases, almost an average of 2 cases per day, with seizure of contrabands of Rs 3,500 crore. The seizure of narcotics drugs and psychotropic substances constitute a major part of it, followed by seizure of gold," Singh said at a Ficci seminar on global challenges of illicit trade and way forward. According to sources, DRI has seized 1,658 kg of gold in 2023-24 fiscal, about 35 per cent more compared to a year ago. Singh said during the fiscal, DRI has also kept a watc

DRI seizes contraband worth Rs 3,500 cr in FY24, drugs major contributor
Updated On : 20 Jun 2024 | 1:38 PM IST

Wealthy Indians jump through hoops to secure weight-loss drugs like Ozempic

Indi had the third largest number of people with obesity as of 2022, behind China and the US, according to a study in The Lancet, with numbers surging as junk food consumption becomes more commonplace

Wealthy Indians jump through hoops to secure weight-loss drugs like Ozempic
Updated On : 19 Jun 2024 | 8:05 AM IST

GSK seeks to appeal Delaware ruling allowing Zantac cases to go forward

The companies, which all sold Zantac at different times, argue that Medinilla should have granted their motion to block plaintiffs from presenting expert testimony that Zantac causes cancer

GSK seeks to appeal Delaware ruling allowing Zantac cases to go forward
Updated On : 11 Jun 2024 | 9:30 AM IST

Pharmaceutical companies prepare to comply with ethical marketing code

Companies must commit that they comply with a code against unethical marketing of drugs

Pharmaceutical companies prepare to comply with ethical marketing code
Updated On : 30 May 2024 | 8:55 PM IST

Jubilant Pharmova Q4 results: Consolidated net loss narrows to Rs 5.86 cr

Revenue from segments that make copycat drugs and medicines used for allergy immunotherapy rose 0.8% and 14%, respectively, during the quarter

Jubilant Pharmova Q4 results: Consolidated net loss narrows to Rs 5.86 cr
Updated On : 29 May 2024 | 4:12 PM IST

GSK's trial drug Depemokimab shows reduction in severe asthma attacks

This form of asthma is characterised by high levels of eosinophils, which is a type of white blood cell.

GSK's trial drug Depemokimab shows reduction in severe asthma attacks
Updated On : 21 May 2024 | 1:46 PM IST

GSK faces lawsuit from lab that found probable carcinogen in Zantac

Big drugmakers already face some 80,000 state suits from users of the drug who say their cancers were caused by Zantac contaminated with NDMA, the dangerous chemical Valisure discovered

GSK faces lawsuit from lab that found probable carcinogen in Zantac
Updated On : 21 May 2024 | 7:24 AM IST

Indian pharma firms supplied 47% of all generic prescriptions in US in 2022

Indian pharmaceutical companies also accounted for a lower but important share of biosimilar production, manufacturing 15 per cent of biosimilar volume used by US patients in 2022

Indian pharma firms supplied 47% of all generic prescriptions in US in 2022
Updated On : 17 May 2024 | 6:47 PM IST

Diabetes to infections: NPPA slashes retail prices of 41 essential drugs

Prices of essential drugs such as dapagliflozin metformin hydrochloride, used for lowering blood glucose levels by decreasing glucose production in the liver, have been fixed at Rs 16 per tablet

Diabetes to infections: NPPA slashes retail prices of 41 essential drugs
Updated On : 16 May 2024 | 11:22 PM IST

Cipla, Glenmark recall drugs from US over manufacturing issues: USFDA

Drug makers Cipla and Glenmark are recalling products from the American market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), a New Jersey-based subsidiary of Cipla is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. The medication, produced at the company's Indore SEZ plant, is used to help control the symptoms of lung diseases, such as asthma, chronic bronchitis and emphysema. Cipla USA is recalling the affected lot due to "short fill". There were complaints of less fill volume in respule and few drops of liquid observed in the intact pouch, USFDA said. Cipla initiated the Class II recall in the US market on March 26 this year. USFDA also said that Glenmark Pharma is recalling 3,264 bottles of Diltiazem Hydrochloride extended-release capsules indicated for high blood pressure. The US-based arm of the company -- Glenmark ...

Cipla, Glenmark recall drugs from US over manufacturing issues: USFDA
Updated On : 05 May 2024 | 11:28 AM IST

Glenmark Pharma receives USFDA nod for generic anti-inflammatory drug

Glenmark Pharmaceuticals on Monday said it has received approval from the US health regulator to sell a generic version of anti-inflammatory drug in the American market. The company has received approval from the US Food and Drug Administration (USFDA) for Acetaminophen and Ibuprofen tablets (250 mg/125 mg), the Mumbai-based drug maker said in a statement. The company's product is the generic version of Haleon US Holdings, LLC's Advil 2 Dual Action with Acetaminophen Tablets, 250 mg/125 mg (OTC), it added. Glenmark Therapeutics Inc, USA will distribute the drug in the US market, the drug maker said. According to Nielsen syndicated data for the latest 52 weeks period ending March 23, 2024, the Advil Dual Action with Acetaminophen Tablets, 250 mg/125 mg achieved annual sales of around USD 84.1 million. Glenmark said its current portfolio consists of 195 products authorised for distribution in the US marketplace and 52 abbreviated new drug applications (ANDAs) pending approval with

Glenmark Pharma receives USFDA nod for generic anti-inflammatory drug
Updated On : 29 Apr 2024 | 11:41 AM IST

13 held with mephedrone worth Rs 230 cr, after raids in Gujarat, Rajasthan

The Gujarat Anti Terrorist Squad and Narcotics Control Bureau jointly raided four units in the state and neighbouring Rajasthan and nabbed 13 persons allegedly with mephedrone worth Rs 230 crore, an official said on Saturday. The raids were carried out on Friday after the ATS received a tip off that Ahmedabad-resident Manoharlal Enani and Kuldeepsinh Rajpurohit of Rajasthan had set up mephedrone manufacturing units. A watch was kept on the movements of Enani and Rajpurohit as well as their accomplices, following which raids were carried out on units in Sirohi and Jodhpur in Rajasthan and Piplaj village in Gandhinagar and Bhaktinagar industrial area of Amreli district in Gujarat, an ATS release informed. "The ATS recovered 22.028 kilograms of mephedrone and 124 kilograms of liquid mephedrone, collectively worth Rs 230 crore. Rajpurohit was nabbed during the raid at Gandhinagar and Enani was held from Sirohi," it said. As per the probe, Enani was in jail for seven years after he was

13 held with mephedrone worth Rs 230 cr, after raids in Gujarat, Rajasthan
Updated On : 27 Apr 2024 | 9:53 PM IST

AstraZeneca trounces Q1 estimates as resilient demand fuels growth

AstraZeneca stuck by its forecast of total revenue and core earnings per share increasing by percentages in the low double-digits to low-teens in 2024

AstraZeneca trounces Q1 estimates as resilient demand fuels growth
Updated On : 25 Apr 2024 | 2:09 PM IST

Govt expands committee for drugs, medical devices pricing reforms

According to an industry source, the committee will also look at ways to design a price moderation framework for medical devices while providing incentives to the medtech industry to minimize imports

Govt expands committee for drugs, medical devices pricing reforms
Updated On : 24 Apr 2024 | 10:32 PM IST

Breaking Bad: What's behind so many meth lab busts in Greater Noida?

Greater Noida is now a surprising hotspot for drug busts involving foreigners running meth labs. In a recent raid, 26.67 kg of drugs valued at Rs 100 crore were seized

Breaking Bad: What's behind so many meth lab busts in Greater Noida?
Updated On : 23 Apr 2024 | 2:52 PM IST

Powered by iPhone exports, electronics become India's fifth largest export

Apple's iPhone exports alone now constitute 35% India's entire electronics export goods basket

Powered by iPhone exports, electronics become India's fifth largest export
Updated On : 17 Apr 2024 | 11:24 PM IST

Glenmark Pharma recalls 6,528 bottles of blood pressure drug in US

Glenmark Pharmaceuticals is recalling 6,528 bottles of a medication used to treat high blood pressure in the American market due to failed dissolution specifications, the US health regulator said. The US-based arm of the Mumbai-headquartered drug firm is recalling the affected lot of Diltiazem Hydrochloride extended-release capsules, the US Food and Drug Administration said in its latest Enforcement Report. The affected lot has been produced in India and is being recalled by New Jersey-based Glenmark Pharmaceuticals Inc for "failed dissolution specifications", the USFDA said. "Out of Specification (OOS) was reported in a test of dissolution at the 12th month time point in long-term stability study," it noted. Glenmark initiated Class II recall of the drug across the US on March 26 this year. As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences

Glenmark Pharma recalls 6,528 bottles of blood pressure drug in US
Updated On : 14 Apr 2024 | 10:57 AM IST